Ovarian endometrial cysts: the role of gonadotropin-releasing hormone agonist and/or drainage
Authors:
- Michelle NisolleMNMichelle Nisolle
- Stephane GillerotSGStephane Gillerot
- Vincent AnafVAVincent Anaf
- Françoise Clerckx-BraunFCFrançoise Clerckx-Braun
- Françoise Casanas-RouxFCFrançoise Casanas-Roux
- 1 July 1994
- journal article
- clinical trial
- Published by Elsevier in Fertility and Sterility
- Vol. 62 (1) , 63-66
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Three-dimensional architectures of peritoneal endometriosisFertility and Sterility, 1992
- Histologic study of peritoneal endometriosis in infertile womenFertility and Sterility, 1990
- Administration of nasal Buserelin as compared with subcutaneous Buserelin implant for endometriosisFertility and Sterility, 1989
- CO 2 Laser Laparoscopy in Peritoneal Endometriosis and in Ovarian Endometrial CystJournal of Gynecologic Surgery, 1989
- Histologic study of ovarian endometriosis after hormonal therapyFertility and Sterility, 1988
- Revised American Fertility Society Classification of Endometriosis: 1985Fertility and Sterility, 1985
- Treatment of endometriosis with danazol: report of a 6-year prospective studyFertility and Sterility, 1985
- Reversible hypogonadism induced by a luteinizing hormone-releasing hormone (LH-RH) agonist (Buserelin) as a new therapeutic approach for endometriosisFertility and Sterility, 1984
- Intranasal treatment with luteinising hormone releasing hormone agonist in women with endometriosis.BMJ, 1983
- “MEDICAL OOPHORECTOMY” USING A LONG-ACTING GNRH AGONIST-A POSSIBLE NEW APPROACH TO THE TREATMENT OF ENDOMETRIOSIS.The Journal of Clinical Endocrinology & Metabolism, 1982